Intra Labs India Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 1.02 M
- Company Age 20 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
About Intra Labs India
Intra Labs India Private Limited (ILIPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 December 2004 and has a history of 20 years and one month. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.02 M, as per Ministry of Corporate Affairs (MCA) records.
Hazarimal Parasmal and Chandravathi serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231KA2004PTC035211
-
Company No.
035211
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Dec 2004
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
What products or services does Intra Labs India Private Limited offer?
Intra Labs India Private Limited offers a wide range of products and services, including Common Disease Medicines, Oral Care Products, Pharmaceutical Syrup, Dry Syrups, Antibiotic Tablets & Capsules, Azithromycin Tablets, Healthcare Products & Aids, Health Drinks, Nutraceuticals & Dietary Supplements, Weight Loss Supplement.
Who are the key members and board of directors at Intra Labs India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hazarimal Parasmal
|
Director | 10-Dec-2004 | Current |
|
Chandravathi
|
Director | 30-Sep-2011 | Current |
Financial Performance of Intra Labs India.
Intra Labs India Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Intra Labs India?
In 2023, Intra Labs India had a public holding of 50.98%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Intra Labs India?
Unlock and access historical data on people associated with Intra Labs India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Intra Labs India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intra Labs India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
